Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.054
AS - Asia 4.265
EU - Europa 3.793
SA - Sud America 714
AF - Africa 101
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.009
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.858
CN - Cina 1.318
SG - Singapore 1.267
IT - Italia 1.037
GB - Regno Unito 931
HK - Hong Kong 588
BR - Brasile 533
SE - Svezia 461
DE - Germania 293
VN - Vietnam 265
RU - Federazione Russa 215
FI - Finlandia 149
JP - Giappone 138
TR - Turchia 138
FR - Francia 135
ID - Indonesia 128
KR - Corea 121
UA - Ucraina 107
CA - Canada 104
IE - Irlanda 104
IN - India 92
AR - Argentina 78
BG - Bulgaria 70
AU - Australia 69
MX - Messico 66
NL - Olanda 58
LT - Lituania 43
PL - Polonia 42
PK - Pakistan 40
TN - Tunisia 39
MY - Malesia 26
AT - Austria 24
EC - Ecuador 23
BD - Bangladesh 22
ES - Italia 22
IQ - Iraq 22
ZA - Sudafrica 22
PE - Perù 21
CL - Cile 19
CO - Colombia 17
HU - Ungheria 17
PT - Portogallo 17
VE - Venezuela 13
BE - Belgio 12
BZ - Belize 12
JO - Giordania 12
PH - Filippine 11
IR - Iran 10
EG - Egitto 9
KE - Kenya 9
MA - Marocco 9
RO - Romania 9
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CH - Svizzera 7
RS - Serbia 7
DK - Danimarca 6
NP - Nepal 6
TH - Thailandia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
IL - Israele 5
PY - Paraguay 5
EU - Europa 4
LU - Lussemburgo 4
OM - Oman 4
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
MU - Mauritius 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IS - Islanda 2
KH - Cambogia 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
Totale 17.002
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.226
Fairfield 853
Singapore 848
Ashburn 750
Hong Kong 567
Chandler 507
Hefei 464
Southend 451
Woodbridge 341
Houston 290
Seattle 275
Nyköping 264
Wilmington 263
London 261
Cambridge 240
Ann Arbor 215
Beijing 180
Los Angeles 147
Jacksonville 142
New York 129
Modena 120
Dearborn 110
Dallas 105
Helsinki 105
Jakarta 101
San Diego 96
Seoul 96
Chicago 89
Ho Chi Minh City 89
Shanghai 87
Milan 83
Moscow 75
Dublin 72
Sofia 70
Princeton 68
Redwood City 64
Buffalo 61
The Dalles 58
Hanoi 57
Munich 55
São Paulo 53
Rome 49
Tokyo 48
Perth 47
Council Bluffs 41
Izmir 41
Bologna 39
Bremen 39
Eugene 36
Salt Lake City 36
Columbus 31
Frankfurt am Main 27
Kent 27
Nuremberg 27
Elk Grove Village 25
Falls Church 25
Manchester 25
San Jose 25
Montreal 24
Warsaw 24
Mexico City 23
San Francisco 23
Bari 21
Boardman 21
Redondo Beach 21
Toronto 21
Brooklyn 20
Ankara 19
Turku 19
Chennai 18
Dong Ket 18
Atlanta 17
Boston 17
Rio de Janeiro 17
Orem 16
Santiago 16
Buenos Aires 15
Catania 15
Istanbul 15
Guangzhou 14
Mumbai 14
Ottawa 14
Brasília 13
Poplar 13
Reggio Nell'emilia 13
Belize City 12
Denver 12
Haiphong 12
Las Vegas 12
Parma 12
Phoenix 12
Stockholm 12
Brussels 11
Da Nang 11
Norwalk 11
Paris 11
Porto Alegre 11
Quito 11
Amsterdam 10
Lappeenranta 10
Totale 11.366
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.218
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 358
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 354
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 303
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 299
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 294
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 279
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 274
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 272
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 272
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 271
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 255
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 251
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 247
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 238
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 232
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 231
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 230
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 226
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 224
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 222
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 217
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 212
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 211
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 209
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 209
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 207
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 198
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 193
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 193
Nailfold videocapillaroscopy in antisynthetase syndrome 193
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 192
Severe alopecia complicating systemic sclerosis 188
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 186
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 185
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 181
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 179
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 176
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 174
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 170
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 168
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 160
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 156
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 155
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 154
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 154
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 153
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 152
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 150
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 147
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 147
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 143
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 143
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 141
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 141
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 139
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 133
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 132
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 130
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 129
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 129
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 128
Fibrosing interstitial lung disease in primary Sjogren syndrome 123
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 118
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 118
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 117
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 116
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 114
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 114
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 113
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 113
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 112
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 111
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 110
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 108
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 108
Rheumatoid arthritis related interstitial lung disease 108
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 108
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 105
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 103
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 103
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 102
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 95
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 94
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 93
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 93
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 93
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 91
Granuloma annulare as a possible new adverse effect of topiramate 89
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 86
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 86
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 85
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 81
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 76
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 75
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 71
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 70
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 69
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 67
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 61
Totale 17.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.234 0 0 0 0 0 135 225 197 184 211 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.678 143 69 108 319 961 737 396 205 489 174 451 626
2025/20263.533 533 368 640 920 975 97 0 0 0 0 0 0
Totale 17.246